Publish Time: 2025-10-31 Origin: Bioteke, Wuxi Biomedical Industry Development Center
In the golden season of autumn, the city of Wuxi became a center of international collaboration for the life sciences. On October 28–29, 2025, the “Belt and Road” Jiangsu Biopharmaceutical Industry Cooperation Event (Wuxi Station) was successfully held, gathering key representatives from Indonesia, Malaysia, Thailand, Vietnam, and leading enterprises from Jiangsu’s thriving biopharmaceutical ecosystem.
This event was co-hosted by the Jiangsu Federation of Returned Overseas Chinese, the Wuxi Federation of Returned Overseas Chinese, and the Wuxi Biopharmaceutical Industry Development Promotion Center, with strong support from several innovation parks and associations. The theme revolved around “Building the Health Silk Road” — promoting global partnerships and advancing the mission of international healthcare collaboration.
The event served as a dynamic platform for dialogue and cooperation, featuring a mix of on-site visits, focused seminars, and B2B networking sessions. Participants explored new pathways in regulatory compliance, market entry strategies, investment opportunities, and technological innovation across Southeast Asia.
Experts shared practical insights on:
Thailand’s TFDA approval process and compliance strategies
Vietnam’s pharmaceutical investment environment and local policy reforms
Malaysia’s NPRA registration and private healthcare market potential
Indonesia’s biosimilar development and localization policies
These sessions provided valuable guidance for Chinese and international biotech companies seeking to expand their presence in emerging healthcare markets under the Belt and Road framework.
Bioteke’s product portfolio covers a wide range of diagnostic solutions, including:
Respiratory pathogen detection kits (antigen and nucleic acid tests)
Sexually transmitted infection (STI) panels
Tumor marker rapid tests
HPV and tropical disease diagnostic kits
Fertility rapid tests(HCG, LH, FSH)
With ISO13485, CE, and FDA certifications, Bioteke provides both professional laboratory solutions and rapid point-of-care testing (POCT) devices that support early disease detection and efficient clinical decision-making.
The “Health Silk Road” initiative represents more than just cooperation in biotechnology — it is a shared commitment to improving healthcare accessibility, fostering scientific innovation, and promoting cross-border partnerships that benefit all.
Through events like the Wuxi Biopharmaceutical Cooperation Meeting, Bioteke continues to deepen its engagement with global partners, driving the development of sustainable, innovative, and inclusive healthcare solutions.
As Bioteke looks toward the future, it remains dedicated to building bridges between nations — linking science, technology, and human well-being across the Belt and Road.